Science

We caught up with Napala Pratini, co-founder at Habitual, which delivers digital therapeutics combined with a nutrition treatment to help people reverse type...

We caught up with Neil Butt, CEO of Orbit Discovery, as part of ‘Product | People | Potential’. Orbit Discovery develop and apply innovative drug...

We caught up with Adedamola (Dammy) Olayanju, Principal Scientist at Manchester BIOGEL, a leader in the supply of peptide hydrogels for use in cell culture,...

We caught up with Piers Kotting, CEO and Co-Founder at RareCan Ltd, a novel company accelerating research into rare cancers. The purpose of article series...

We caught up with Özgür Tuncer, CEO and Executive Director of Stablepharma, as part of ‘Product | People | Potential’. StablevaX™ made by Stablep...

We caught up with Jenny Barnett, CEO at Monument Therapeutics where they use digital biomarkers to improve neuroscience drug development. The purpose of arti...

We caught up with Arda Ozcubukcu, Co-Founder and Director at NeuroSight, a harm reduction organisation preventing avoidable deaths and reducing drug-related ...

We caught up with Isaac Johnson CEO at Verinnogen, where they are designing tools for measuring the properties of 3D surfaces for use in oncology...

We caught up we caught up with Jenny Bailey, Chief Executive Officer at Ferryx, working on the development of innovative bacterial treatments for gastrointes...

We caught up with Dr. Edoardo Gaude, Co-Founder and Chief Scientific Officer at Pockit Diagnostics which is developing a tool for faster and more accurate...

We caught up with Henri Sant-Cassia, founding Director at The Conscious Fund, a global investor in early-stage ventures within psychedelic medicine, helping ...

We caught up with Abi Hannah, Co-Founder & CEO at Fertility Circle, a new kind of fertility platform. The purpose of article series ‘Product |...